Plx Pharma Inc (PLXP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PLXP Annual Balance Sheets →
From Plx Pharma Inc through Sep 30 2021, shifts in Sep 30 2022's assets and liabilities provide insight into the company's capital structure and financial stability.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2022)
(Jun 30 2022) (Mar 31 2022) (Dec 31 2021) (Sep 30 2021)
Assets
Cash & cash equivalent25.83
Cash & Short-term Investments25.00
Accounts receivable0.14
Deferred Costs, Current AS3.18
Prepaid Expense And Other Assets Current1.07
Total Current Assets30.22
Equipment/Property/Plant Net0.77
Goodwill net2.06
Deposits Assets, Noncurrent AS0.00
Other Assets, Noncurrent0.17
Operating Lease Right Of Use Asset0.00
Total Assets33.22
Liabilities
Accounts Payable and Accrued Liabilities, Current LI5.07
Other Liabilities, Current0.13
Total Current Liabilities6.31
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.54
Other liabilities, Noncurrent0.05
Accrued Bonuses And Severances Current1.11
Dividends Payable Noncurrent0.13
Total Liabilities7.02
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock189.57
Retained Earnings / Accumulated Deficit-179.41
Other Equity-13.71
Common Stockholder's Equity-3.52
Non-controlling interests & other13.71
Total Stockholder's Equity10.19
Liabilities & Stockholder's Equity33.22
4 historic quarters locked

Sign in to unlock the full Plx Pharma Inc balance sheet history.

About Plx Pharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-22-026958

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.